|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global Cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hamer M, Chida Y and Molloy GJ:
Psychological distress and cancer mortality. J Psychosom Res.
66:255–258. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guimaraes S and Moura D: Vascular
adrenoceptors: an update. Pharmacol Rev. 53:319–356.
2001.PubMed/NCBI
|
|
4
|
Masur K, Niggemann B, Zanker KS and
Entschladen F: Norepinephrine-induced migration of SW 480 colon
carcinoma cells is inhibited by beta-blockers. Cancer Res.
61:2866–2869. 2001.PubMed/NCBI
|
|
5
|
Wong HP, Ho JW, Koo MW, et al: Effects of
adrenaline in human colon adenocarcinoma HT-29 cells. Life Sci.
88:1108–1112. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu WK, Wong HP, Luo SW, et al:
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone from cigarette smoke
stimulates colon cancer growth via beta-adrenoceptors. Cancer Res.
65:5272–5277. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Galandrin S and Bouvier M: Distinct
signaling profiles of beta1 and beta2 adrenergic receptor ligands
toward adenylyl cyclase and mitogen-activated protein kinase
reveals the pluridimensionality of efficacy. Mol Pharmacol.
70:1575–1584. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lutgendorf SK, Sood AK and Antoni MH: Host
factors and cancer progression: biobehavioral signaling pathways
and interventions. J Clin Oncol. 28:4094–4099. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Al-Wadei HA, Al-Wadei MH and Schuller HM:
Cooperative regulation of non-small cell lung carcinoma by
nicotinic and beta-adrenergic receptors: a novel target for
intervention. PLoS One. 7:e299152012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Thaker PH, Han LY, Kamat AA, et al:
Chronic stress promotes tumor growth and angiogenesis in a mouse
model of ovarian carcinoma. Nat Med. 12:939–944. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bernabe DG, Tamae AC, Biasoli ER and
Oliveira SH: Stress hormones increase cell proliferation and
regulate interleukin-6 secretion in human oral squamous cell
carcinoma cells. Brain Behav Immun. 25:574–583. 2011. View Article : Google Scholar
|
|
12
|
Perez Pinero C, Bruzzone A, Sarappa MG,
Castillo LF and Lüthy IA: Involvement of α2- and β2-adrenoceptors
on breast cancer cell proliferation and tumour growth regulation.
Br J Pharmacol. 166:721–736. 2012. View Article : Google Scholar
|
|
13
|
Zhang P, He X, Tan J, Zhou X and Zou L:
β-arrestin2 mediates β-2 adrenergic receptor signaling inducing
prostate cancer cell progression. Oncol Rep. 26:1471–1477.
2011.PubMed/NCBI
|
|
14
|
Stanojkovic TP, Zizak Z,
Mihailovic-Stanojevic N, Petrovic T and Juranic Z: Inhibition of
proliferation on some neoplastic cell lines-act of carvedilol and
captopril. J Exp Clin Cancer Res. 24:387–395. 2005.PubMed/NCBI
|
|
15
|
Miranda CL, Stevens JF, Helmrich A, et al:
Antiproliferative and cytotoxic effects of prenylated flavonoids
from hops (Humulus lupulus) in human cancer cell lines. Food Chem
Toxicol. 37:271–285. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
McDonald PG, Antoni MH, Lutgendorf SK, et
al: A biobehavioral perspective of tumor biology. Discov Med.
5:520–526. 2005.PubMed/NCBI
|
|
17
|
Chida Y, Hamer M, Wardle J and Steptoe A:
Do stress-related psychosocial factors contribute to cancer
incidence and survival? Nat Clin Pract Oncol. 5:466–475. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cole SW and Sood AK: Molecular pathways:
beta-adrenergic signaling in cancer. Clin Cancer Res. 18:1201–1206.
2012. View Article : Google Scholar :
|
|
19
|
Zhang D, Ma Q, Wang Z, Zhang M, Guo K,
Wang F and Wu E: β2-adrenoceptor blockage induces G1/S phase arrest
and apoptosis in pancreatic cancer cells via Ras/Akt/NFκB pathway.
Mol Cancer. 10:1462011. View Article : Google Scholar
|
|
20
|
Chakroborty D, Sarkar C, Basu B, Dasgupta
PS and Basu S: Catecholamines regulate tumor angiogenesis. Cancer
Res. 69:3727–3730. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Perez-Sayans M, Somoza-Martin JM,
Barros-Angueira F, Diz PG, Gandara Rey JM and Garcia-Garcia A:
Beta-adrenergic receptors in cancer: therapeutic implications.
Oncol Res. 19:45–54. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang D, Ma QY, Hu HT and Zhang M:
β2-adrenergic antagonists suppress pancreatic cancer cell invasion
by inhibiting CREB, NFκB and AP-1. Cancer Biol Ther. 10:19–29.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin Q, Wang F, Yang R, Zheng X, Gao H and
Zhang P: Effect of chronic restraint stress on human colorectal
carcinoma growth in mice. PLoS One. 8:e614352013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rajagopal S, Rajagopal K and Lefkowitz RJ:
Teaching old receptors new tricks: biasing seven-transmembrane
receptors. Nat Rev Drug Discov. 9:373–386. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ji Y, Chen S, Li K, Xiao X, Zheng S and Xu
T: The role of β-adrenergic receptor signaling in the proliferation
of hemangioma-derived endothelial cells. Cell Div. 8:12013.
View Article : Google Scholar
|
|
26
|
Wisler JW, DeWire SM, Whalen EJ, et al: A
unique mechanism of beta-blocker action: carvedilol stimulates
beta-arrestin signaling. Proc Natl Acad Sci USA. 104:16657–16662.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Baker JG, Hill SJ and Summers RJ:
Evolution of β-blockers: from anti-anginal drugs to ligand-directed
signalling. Trends Pharmacol Sci. 32:227–234. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dhillon AS, Hagan S, Rath O and Kolch W:
MAP kinase signalling pathways in cancer. Oncogene. 26:3279–3290.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Barron TI, Sharp L and Visvanathan K:
Beta-adrenergic blocking drugs in breast cancer: a perspective
review. Ther Adv Med Oncol. 4:113–125. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shenoy SK, Drake MT, Nelson CD, et al:
Beta-arrestin-dependent, G protein-independent ERK1/2 activation by
the beta2 adrenergic receptor. J Biol Chem. 281:1261–1273. 2006.
View Article : Google Scholar
|
